Ignite Creation Date:
2024-05-06 @ 7:47 PM
Last Modification Date:
2024-10-26 @ 3:14 PM
Study NCT ID:
NCT06136884
Status:
RECRUITING
Last Update Posted:
2024-05-16
First Post:
2023-11-07
Brief Title:
A First-In-Human Phase 1 Study Evaluating Oral TACC3 PPI Inhibitor AO-252 in Advanced Solid Tumors
Sponsor:
A2A Pharmaceuticals Inc
Organization:
A2A Pharmaceuticals Inc
Organization Data
Organization:
A2A Pharmaceuticals Inc
Class:
INDUSTRY
Study ID:
A2A-O-004
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
A2A Pharmaceuticals Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None